Status:
RECRUITING
Non-invasive Monitoring of Miscarriage
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Miscarriage in First Trimester
Eligibility:
All Genders
18-45 years
Brief Summary
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) ...
Detailed Description
Pregnancies achieved by assisted reproductive technologies (ART) are closely monitored, therefore miscarriages that occur very early in the pregnancy are frequently meticulously recorded and reported....
Eligibility Criteria
Inclusion
- Age 18-45 years.
- Women who attend the early pregnancy loss clinic or Patients who receive ART
- Their partner, the biological father of the pregnancy
Exclusion
- History of psychological/ psychiatric problem
- Patient refusal
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2039
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06581692
Start Date
September 1 2024
End Date
August 31 2039
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong